![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/395 | (2013.01) |
A61P 35/00 | (2006.01) | ||
C07K 16/28 | (2006.01) | ||
C07K 16/28 | (2013.01) | ||
A61K 39/395 | (2006.01) | ||
C07K 16/2818 | (2013.01) | ||
C07K2317/22 | (2013.01) | ||
C07K2317/60 | (2013.01) | ||
A61P 1/04 | (2018.01) | ||
A61P 1/16 | (2018.01) | ||
A61P 11/00 | (2018.01) | ||
A61P 11/02 | (2018.01) | ||
A61P 13/10 | (2018.01) | ||
A61P 13/12 | (2018.01) | ||
A61P 15/00 | (2018.01) | ||
A61P 17/00 | (2018.01) | ||
A61P 19/08 | (2018.01) | ||
A61P 25/00 | (2018.01) | ||
A61P 31/00 | (2018.01) | ||
A61P 31/04 | (2018.01) | ||
A61P 31/12 | (2018.01) | ||
A61P 31/16 | (2018.01) | ||
A61P 31/18 | (2018.01) | ||
A61P 31/22 | (2018.01) | ||
A61P 33/02 | (2018.01) | ||
A61P 33/06 | (2018.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 35/02 | (2018.01) | ||
A61P 7/00 | (2018.01) |
(11) | Number of the document | 3459597 |
(13) | Kind of document | T |
(96) | European patent application number | 17798775.7 |
Date of filing the European patent application | 2017-05-19 | |
(97) | Date of publication of the European application | 2019-03-27 |
(45) | Date of publication and mention of the grant of the patent | 2022-08-31 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CN2017/085038 |
Date | 2017-05-19 |
(87) | Number | WO 2017/198212 |
Date | 2017-11-23 |
(30) | Number | Date | Country code |
201610332590 | 2016-05-19 | CN |
(72) |
XU, Ting , CN
WANG, Xiaoxiao , CN
LI, Jie , CN
WU, Haiyan , CN
GAO, Li , CN
CHU, Qian , CN
BAI, Yu , CN
|
(73) |
Suzhou Alphamab Co., Ltd ,
Building C23 BioBay
Xinghu Street
No. 218 Suzhou, Jiangsu 215125,
CN
Zhang, Xitian , 666-2 Dapu Road Room 2001 Huangpu District, Shanghai 200023, CN Zhang, Xin , Building 6, Room 1701, No.800 Dongan Road, Xuhui District,, Shanghai 200032, CN |
(54) | SINGLE DOMAIN ANTIBODY FOR CTLA4 AND DERIVED PROTEIN THEREOF |
SINGLE DOMAIN ANTIBODY FOR CTLA4 AND DERIVED PROTEIN THEREOF |